Literature DB >> 12097314

Basal circadian cortisol secretion in women with temporomandibular disorders.

A Korszun1, E A Young, K Singer, N E Carlson, M B Brown, L Crofford.   

Abstract

Muscular temporomandibular disorder (TMD) is a common stress-related condition showing marked comorbidity with depression and fibromyalgia (FM), both of which are associated with dysregulation of cortisol secretion. We measured cortisol levels in 15 women with well-defined TMD and 15 matched controls by sampling blood at 10-minute intervals over 24 hours in a controlled environment. TMD patients showed markedly increased daytime cortisol levels 30% to 50% higher than those of controls (p = 0.0032) and a one-hour phase delay in the timing of maximum cortisol levels (p = 0.048). Increased activation of the stress hormone axis by conscious pain perception is a likely explanation, but the magnitude of the increase could indicate that pain in the facial region acts as a greater stimulus than pain elsewhere in the body.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12097314     DOI: 10.1177/154405910208100411

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  17 in total

1.  Potential genetic risk factors for chronic TMD: genetic associations from the OPPERA case control study.

Authors:  Shad B Smith; Dylan W Maixner; Joel D Greenspan; Ronald Dubner; Roger B Fillingim; Richard Ohrbach; Charles Knott; Gary D Slade; Eric Bair; Dustin G Gibson; Dmitri V Zaykin; Bruce S Weir; William Maixner; Luda Diatchenko
Journal:  J Pain       Date:  2011-11       Impact factor: 5.820

2.  Adrenergic dysregulation and pain with and without acute beta-blockade in women with fibromyalgia and temporomandibular disorder.

Authors:  Kathleen C Light; Edith E Bragdon; Karen M Grewen; Kimberly A Brownley; Susan S Girdler; William Maixner
Journal:  J Pain       Date:  2009-05       Impact factor: 5.820

Review 3.  Cognitive impairment in patients with chronic pain: the significance of stress.

Authors:  Robert P Hart; James B Wade; Michael F Martelli
Journal:  Curr Pain Headache Rep       Date:  2003-04

Review 4.  How may stressful experiences contribute to the development of temporomandibular disorders?

Authors:  Gustavo Hauber Gameiro; Annicele da Silva Andrade; Darcy Flávio Nouer; Maria Cecília Ferraz de Arruda Veiga
Journal:  Clin Oral Investig       Date:  2006-08-22       Impact factor: 3.573

5.  Prevalence and associated factors for temporomandibular disorders in Chinese civilian pilots.

Authors:  Qing Yu; Yang Liu; Xi Chen; Duanjing Chen; Lu Xie; Xiao Hong; Xingyuan Wang; Haili Huang; Haiyang Yu
Journal:  Int Arch Occup Environ Health       Date:  2015-01-17       Impact factor: 3.015

6.  Increased Risk of Temporomandibular Joint Disorder in Osteoporosis Patients: A Longitudinal Study.

Authors:  So Young Kim; Dae Myoung Yoo; Mi Jung Kwon; Ji Hee Kim; Joo-Hee Kim; Soo-Hwan Byun; Bumjung Park; Hyo-Jeong Lee; Hyo Geun Choi
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-31       Impact factor: 5.555

7.  Association between stress, sleep quality and temporomandibular joint dysfunction: simulated Mars mission.

Authors:  Balwant Rai; Jasdeep Kaur
Journal:  Oman Med J       Date:  2013-05

8.  Pain catastrophizing and salivary cortisol responses to laboratory pain testing in temporomandibular disorder and healthy participants.

Authors:  Phillip J Quartana; Luis F Buenaver; Robert R Edwards; Brendan Klick; Jennifer A Haythornthwaite; Michael T Smith
Journal:  J Pain       Date:  2009-10-22       Impact factor: 5.820

9.  Modulation of paratrigeminal nociceptive neurons following temporomandibular joint inflammation in rats.

Authors:  Yoko Yamazaki; Ke Ren; Masahiko Shimada; Koichi Iwata
Journal:  Exp Neurol       Date:  2008-08-22       Impact factor: 5.330

10.  Dysregulation of the autonomous nervous system in patients with temporomandibular disorder: a pupillometric study.

Authors:  Annalisa Monaco; Ruggero Cattaneo; Luca Mesin; Irma Ciarrocchi; Fabrizio Sgolastra; Davide Pietropaoli
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.